Fermenta Biotech Ltd · BSE:FERMENTA
Fermenta Biotech — Q3 FY2025 Earnings Presentation
20 slides from Fermenta Biotech's earnings presentation, Feb 18, 2025
Slide 1: BSE filing cover letter: intimation of earnings presentation
Ref: F.No.:908 February 18, 2025 Corporate Relations BSE Limited, Phiroze Jeejeebhoy Towers, Dalal Street, Fort, Mumbai – 400 001 Dear Sir, Sub.: Intimation of Earnings Presentation for Quarter 3 of Financial Year (‘FY’) 2024-25 [Q3/9M-FY25] Ref: Scrip Code: 506414 Further to our intimation dated Fe
Slide 2: Earnings Presentation | Q3/9M-FY25
Earnings Presentation | Q3/9M-FY25
Slide 3: Snapshot
Snapshot Top 3 Only manufacturer of Amongst top 3 manufacturers Global Presence in Vitamin D3 in India of Vitamin D3 globally 60+ countries Proprietary technology to 55 Years of Vitamin D3 Both manufacturing facilities certified manufacture Vitamin D3 manufacturing experience by global regulatory bo
Slide 4: Company Overview
Company Overview • Fermenta Biotech Limited (FBL) (Erstwhile DIL Ltd.) incorporated in 1951 by Dr. DVK Raju, is engaged in development and manufacturing of pharmaceuticals, biotechnology and environmental solutions used across various industries. Consolidated Revenue (INR Mn) & Operational EBITDA Ma
Slide 5: Segmental Revenue (Consolidated)
Segmental Revenue (Consolidated) Nutrition Business Vitamin D3 - Human Nutrition (INR Mn) Vitamin D3 - Animal Nutrition (INR Mn) Others (INR Mn) 621 304 289 120 106 99 381 323 126 Q3-FY24 Q2-FY25 Q3-FY25 Q3-FY24 Q2-FY25 Q3-FY25 Q3-FY24 Q2-FY25 Q3-FY25 Non-Nutrition Business Other APIs and Intermedia
Slide 6: Financial Overview
Q3/9M-FY25 FINANCIAL OVERVIEW
Slide 7: Q3/9M-FY25 Financial Highlights
Q3/9M-FY25 Financial Highlights Q3-FY25 Standalone Performance 9M-FY25 Standalone Performance INR 1,463 Mn INR 501 Mn 34.24% INR 3,085 Mn INR 675 Mn 21.88% Operational Income Operational EBITDA* Operational EBITDA Margin Operational Income Operational EBITDA* Operational EBITDA Margin INR 350 Mn 23.
Slide 8: Q3/9M-FY25 Operational Highlights
Q3/9M-FY25 Operational Highlights Geographical Revenue Mix % (9M-FY25) • Q3-FY25 Revenue excluding real estate (and transfer of lease-related rights) INR 118 crore, up (Excluding Real Estate) 105% YoY; up 28 % QoQ; on the back of strong volume and price growth in both Human and Others Animal Nutriti
Slide 9: Vitamin D3 Animal Feed Price Trend
Vitamin D3 500 Animal Feed Price Trend 85 80 75 60 50 Price (Euro/kg) 40 35 33 30 25 22 32 20 20 16 12 10 8 13 12 10 8 8 9 6 6 6 7 7 7 7 7 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Source: feedinfo.com Calendar Year Min of Low Max of High Fermenta Bi
Slide 10: Quarterly Standalone Financial Performance
Quarterly Standalone Financial Performance PARTICULARS (INR Mn) Q3-FY25 Q3-FY24 Y-o-Y Q2-FY25 Q-o-Q Operational Revenue 1,463 894 63.6% 895 63.5% Total Expenses 962 629 52.9% 739 30.2% Operational EBITDA* 501 265 89.1% 156 NA Operational EBITDA Margins (%) 34.24% 29.64% 460 Bps 17.43% NA Other Incom
Slide 11: YTD Standalone Financial Performance
YTD Standalone Financial Performance PARTICULARS (INR Mn) 9M-FY25 9M-FY24 Y-o-Y Operational Revenue 3,085 2,174 41.9% Total Expenses 2,410 1,894 27.2% Operational EBITDA* 675 280 NA Operational EBITDA Margins (%) 21.88% 12.88% 900 Bps Other Income 78 67 16.4% Depreciation 176 175 0.6% Finance Cost 1
Slide 12: Quarterly Consolidated Financial Performance
Quarterly Consolidated Financial Performance PARTICULARS (INR Mn) Q3-FY25 Q3-FY24 Y-o-Y Q2-FY25 Q-o-Q Operational Revenue 1,565 990 58.1% 950 64.7% Total Expenses 1,032 738 39.8% 763 35.3% Operational EBITDA* 533 252 NA 187 NA Operational EBITDA Margins (%) 34.06% 25.45% 861 Bps 19.68% NA Other Inco
Slide 13: YTD Consolidated Financial Performance
YTD Consolidated Financial Performance PARTICULARS (INR Mn) 9M-FY25 9M-FY24 Y-O-Y Operational Revenue 3,296 2,383 38.3% Total Expenses 2,567 2,161 18.8% Operational EBITDA* 729 222 NA Operational EBITDA Margins (%) 22.12% 9.32% NA Other Income 79 64 23.4% Depreciation 184 183 0.5% Finance Cost 112 1
Slide 14: Historical Standalone Income Statement
Historical Standalone Income Statement PARTICULARS (INR Mn) 9M-FY25 FY24 FY23 FY22 Operational Revenue 3,085 3,071 3,289 3,880 Total Expenses 2,410 2,701 2,905 3,120 Operational EBITDA* 675 370 384 760 Operational EBITDA Margins (%) 21.88% 12.05% 11.68% 19.59% Other Income 78 82 85 75 Depreciation 1
Slide 15: Historical Consolidated Income Statement
Historical Consolidated Income Statement PARTICULARS (INR Mn) 9M-FY25 FY24 FY23 FY22 Operational Revenue 3,296 3,357 3,499 3,985 Total Expenses 2,567 3,082 3,323 3,371 Operational EBITDA* 729 275 176 614 Operational EBITDA Margins (%) 22.12% 8.19% 5.12% 15.41% Other Income 79 118 86 81 Depreciation
Slide 16: Historical Standalone Balance Sheet
Historical Standalone Balance Sheet PARTICULARS (INR Mn) H1-FY25 FY24 FY23 PARTICULARS (INR Mn) H1-FY25 FY24 FY23 Equity 3,150 3,142 3,360 Assets Non-current Assets 3,165 3,264 4,105 a) Equity share capital 145 144 144 a) Property, plant and equipment 2,291 2,364 2,048 b) Other equity 3,005 2,998 3,
Slide 17: Historical Consolidated Balance Sheet
Historical Consolidated Balance Sheet PARTICULARS (INR Mn) H1-FY25 FY24 FY23 PARTICULARS (INR Mn) H1-FY25 FY24 FY23 Equity 2,860 2,851 3,126 Assets a) Equity share capital 145 144 144 Non-current Assets 2,949 3,061 3,835 a) Property, plant and equipment 2,291 2,364 2,048 b) Other equity 2,756 2,744
Slide 18: Historical Consolidated Financial Performance
Historical Consolidated Financial Performance Operational Revenue (INR Mn) Operational EBITDA* (INR Mn) & Margins (%) PAT (INR Mn) & Margins (%) 3,985 431 729 3,499 13.08% 3,357 3,296 614 22.12% 154 3.86% 15.41% 275 FY22 FY23 FY24 9M-FY25 -7.15% 176 8.19% -240 5.12% -15.18% -531 FY22 FY23 FY24 9M-FY
Slide 19: Disclaimer
Disclaimer No representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, completeness or correctness of the information or opinions contained in this presentation. Such information and opinions are in all events not current after the d
Slide 20: Thank You
Thank You